KPCB XV Founders Fund, LLC 4

Accession 0001209191-19-055030

CIK 0001673772other

Filed

Nov 3, 7:00 PM ET

Accepted

Nov 4, 6:49 PM ET

Size

23.7 KB

Accession

0001209191-19-055030

Form 4

Period: 2019-11-04

10% Owner

Transactions

Conversion
Series A Preferred Stock
2019-11-04−17,228,956→ 0 total(indirect: By KPCB Holdings, Inc., as)
→ Common Stock (2,871,492 underlying)
Conversion
Series C Preferred Stock
2019-11-04−2,181,025→ 0 total(indirect: By KPCB Holdings, Inc., as)
→ Common Stock (363,504 underlying)
Conversion
Common Stock
2019-11-04+166,666→ 3,038,158 total(indirect: By KPCB Holdings, Inc., as)
Conversion
Series B Preferred Stock
2019-11-04−1,000,000→ 0 total(indirect: By KPCB Holdings, Inc., as)
→ Common Stock (166,666 underlying)
Conversion
Common Stock
2019-11-04+2,871,492→ 2,871,492 total(indirect: By KPCB Holdings, Inc., as)
Conversion
Series C-2 Preferred Stock
2019-11-04−872,410→ 0 total(indirect: By KPCB Holdings, Inc., as)
→ Common Stock (145,401 underlying)
Conversion
Common Stock
2019-11-04+363,504→ 3,401,662 total(indirect: By KPCB Holdings, Inc., as)
Conversion
Common Stock
2019-11-04+145,401→ 3,547,063 total(indirect: By KPCB Holdings, Inc., as)

10% Owner

Transactions

Conversion
Common Stock
2019-11-04+145,401→ 3,547,063 total(indirect: By KPCB Holdings, Inc., as)
Conversion
Series A Preferred Stock
2019-11-04−17,228,956→ 0 total(indirect: By KPCB Holdings, Inc., as)
→ Common Stock (2,871,492 underlying)
Conversion
Common Stock
2019-11-04+2,871,492→ 2,871,492 total(indirect: By KPCB Holdings, Inc., as)
Conversion
Common Stock
2019-11-04+166,666→ 3,038,158 total(indirect: By KPCB Holdings, Inc., as)
Conversion
Series B Preferred Stock
2019-11-04−1,000,000→ 0 total(indirect: By KPCB Holdings, Inc., as)
→ Common Stock (166,666 underlying)
Conversion
Series C Preferred Stock
2019-11-04−2,181,025→ 0 total(indirect: By KPCB Holdings, Inc., as)
→ Common Stock (363,504 underlying)
Conversion
Common Stock
2019-11-04+363,504→ 3,401,662 total(indirect: By KPCB Holdings, Inc., as)
Conversion
Series C-2 Preferred Stock
2019-11-04−872,410→ 0 total(indirect: By KPCB Holdings, Inc., as)
→ Common Stock (145,401 underlying)

10% Owner

Transactions

Conversion
Common Stock
2019-11-04+166,666→ 3,038,158 total(indirect: By KPCB Holdings, Inc., as)
Conversion
Common Stock
2019-11-04+145,401→ 3,547,063 total(indirect: By KPCB Holdings, Inc., as)
Conversion
Series C Preferred Stock
2019-11-04−2,181,025→ 0 total(indirect: By KPCB Holdings, Inc., as)
→ Common Stock (363,504 underlying)
Conversion
Series C-2 Preferred Stock
2019-11-04−872,410→ 0 total(indirect: By KPCB Holdings, Inc., as)
→ Common Stock (145,401 underlying)
Conversion
Common Stock
2019-11-04+2,871,492→ 2,871,492 total(indirect: By KPCB Holdings, Inc., as)
Conversion
Common Stock
2019-11-04+363,504→ 3,401,662 total(indirect: By KPCB Holdings, Inc., as)
Conversion
Series A Preferred Stock
2019-11-04−17,228,956→ 0 total(indirect: By KPCB Holdings, Inc., as)
→ Common Stock (2,871,492 underlying)
Conversion
Series B Preferred Stock
2019-11-04−1,000,000→ 0 total(indirect: By KPCB Holdings, Inc., as)
→ Common Stock (166,666 underlying)

Footnotes (2)

[F1]At the closing of the Issuer's initial public offering, each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, and Series C-2 Preferred Stock of the Issuer (collectively, the "Preferred Stock") automatically converted into approximately 0.166 shares of the Issuer's common stock (on an adjusted basis, after giving effect to the 1-for-6 reverse stock split of the common stock effected by the Issuer on July 19, 2019) for no additional consideration. Shares of Preferred Stock have no expiration date.
[F2]The shares held for convenience in the name of KPCB Holdings, Inc., as nominee for the accounts of the following entities as follows: 3,444,199 shares held for the account of Kleiner Perkins Caufield & Byers XV, LLC ("KPCB XV") and 102,864 shares held for the account of KPCB XV Founders Fund, LLC ("KPCB XV FF"). The managing member of KPCB XV and KPCB XV FF is KPCB XV Associates, LLC ("KPCB XV Associates"). Beth Seidenberg, L. John Doerr, Randy Komisar, Theodore E. Schlein, Wen Hsieh and William "Bing" Gordon, the managing members of KPCB XV Associates, exercise shared voting and dispositive control over the shares held by KPCB Holdings, Inc. as nominee for the accounts of KPCB XV and KPCB XV FF.

Documents

1 file

RAPT Therapeutics, Inc.

CIK 0001673772

Entity typeother

IncorporatedDE